rachel_brandeis_pcos_pmos_ead_img_b

Why PCOS is Now PMOS: What the Name Change Means for You

Polyendocrine Metabolic Ovarian Syndrome reflects whole-body health, not just cysts.

For many years, Polycystic Ovary Syndrome (PCOS) has been the name used to describe this common hormonal and metabolic condition. However, the name has long been recognized as medically misleading.

Many people diagnosed with PCOS do not have ovarian cysts. In addition, the condition affects far more than the ovaries. It can influence hormone balance, metabolism, insulin function, weight regulation, fertility, skin health, and long-term cardiovascular and metabolic health.

The term Polymetabolic Ovary Syndrome (PMOS) more accurately reflects the complex nature of the condition by recognizing that it is a metabolic and endocrine disorder, not simply an ovarian condition.

Why the Change Matters

Changing the name to PMOS helps to:

  • Better reflect the underlying biology of the condition.
  • Encourage earlier recognition and diagnosis, even when ovarian cysts are absent.
  • Highlight the important metabolic features, including insulin resistance and increased risk of type 2 diabetes and cardiovascular disease.
  • Support a more comprehensive approach to treatment that addresses both hormonal and metabolic health.

The shift toward PMOS reflects ongoing efforts to use terminology that is more accurate and better represents the full spectrum of the condition to promote greater understanding, earlier diagnosis, and more personalized care.

Scroll to Top